These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8759360)

  • 1. Platelet activating factor inhibits fluid transport by corneal endothelium.
    Zhu Z; Kuang K; Kang F; Li J; Fischbarg J
    Invest Ophthalmol Vis Sci; 1996 Aug; 37(9):1899-906. PubMed ID: 8759360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Release of platelet activating factor (PAF) and eicosanoids in UVC-irradiated corneal stromal cells.
    Sheng Y; Birkle DL
    Curr Eye Res; 1995 May; 14(5):341-7. PubMed ID: 7648859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary hypertension and edema induced by platelet-activating factor in isolated, perfused rat lungs are blocked by BN52021.
    Imai T; Vercellotti GM; Moldow CF; Jacob HS; Weir EK
    J Lab Clin Med; 1988 Feb; 111(2):211-7. PubMed ID: 3339274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term and long-term role of platelet activating factor as a mediator of in vivo platelet aggregation.
    Golino P; Ambrosio G; Ragni M; Pascucci I; Triggiani M; Oriente A; McNatt J; Buja LM; Condorelli M; Chiariello M
    Circulation; 1993 Sep; 88(3):1205-14. PubMed ID: 8353882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Corneal epithelial wound healing is delayed by platelet activating factor treatment].
    Ma X; Ni CX; Bazan H; Sun HC
    Zhonghua Yan Ke Za Zhi; 2004 Mar; 40(3):151-5. PubMed ID: 15307983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A platelet-activating factor antagonist reduces corneal allograft inflammation and neovascularization.
    Cohen RA; Gebhardt BM; Bazan NG
    Curr Eye Res; 1994 Feb; 13(2):139-44. PubMed ID: 8194360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-leukocyte interaction in adhesion to endothelial cells induced by platelet-activating factor in vitro.
    Hirafuji M; Shinoda H
    Br J Pharmacol; 1991 Jun; 103(2):1333-8. PubMed ID: 1884095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonist of platelet-activating factor prevents prostaglandin E2 induced ocular hypertension in rabbits.
    Jager GV; van Delft JL; van Haeringen NJ; Verbeij NL; Braquet P
    Prostaglandins; 1993 Jan; 45(1):97-105. PubMed ID: 8424134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro effects of PAF on venous endothelial cell actin disposition.
    Northover AM
    Agents Actions; 1992 Jan; 35(1-2):40-9. PubMed ID: 1509977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of PAF and PAF antagonists on the shape of venous endothelial cells in vitro.
    Northover AM
    Agents Actions; 1989 Aug; 28(1-2):142-8. PubMed ID: 2551151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of platelet activating factor antagonists on cultured rat mesangial cells.
    Neuwirth R; Singhal P; Satriano JA; Braquet P; Schlondorff D
    J Pharmacol Exp Ther; 1987 Nov; 243(2):409-14. PubMed ID: 3119816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-activating factor induces the expression of metalloproteinases-1 and -9, but not -2 or -3, in the corneal epithelium.
    Tao Y; Bazan HE; Bazan NG
    Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):345-54. PubMed ID: 7843905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the platelet activating factor antagonist BN52021 in rabbits: role in gentamicin nephrotoxicity.
    Hanslik T; Blanchet F; Nochy D; Pirotzky E; Guilmard C; Seta N; Carbon C
    Toxicol Appl Pharmacol; 1994 Sep; 128(1):111-5. PubMed ID: 8079343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human endothelial cells are targets for platelet-activating factor (PAF). Activation of alpha and beta protein kinase C isozymes in endothelial cells stimulated by PAF.
    Bussolino F; Silvagno F; Garbarino G; Costamagna C; Sanavio F; Arese M; Soldi R; Aglietta M; Pescarmona G; Camussi G
    J Biol Chem; 1994 Jan; 269(4):2877-86. PubMed ID: 7507929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of platelet-activating factor on arteriolar and venular tone in rat trachea.
    Collins LC; Roberts AM
    Microvasc Res; 1997 Jan; 53(1):63-72. PubMed ID: 9056476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for platelet-activating factor as a late-phase mediator of chronic pancreatitis in the rat.
    Zhou WG; Chao W; Levine BA; Olson MS
    Am J Pathol; 1990 Dec; 137(6):1501-8. PubMed ID: 1701964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of specific binding sites for PAF in the iris and ciliary body of rabbit.
    Domingo MT; Chabrier PE; Van Delft JL; Verbeij NL; Van Haeringen NJ; Braquet P
    Biochem Biophys Res Commun; 1989 Apr; 160(1):250-6. PubMed ID: 2540746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of platelet activating factor and platelet activating factor receptor antagonist on spinal cord blood flow after spinal cord injury].
    Xiao J; Zao D; Zhen H
    Zhonghua Wai Ke Za Zhi; 1995 Dec; 33(12):715-8. PubMed ID: 8762548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of MTX and BN52021 on PAF-induced chemotaxis of PMNs and intraepidermal accumulation of inflammatory cells in guinea pigs.
    Liu B; Zhang H; Li S; Chen W
    Chin Med J (Engl); 1996 Jun; 109(6):467-70. PubMed ID: 9206081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet activating factor induces dopamine release in PC-12 cell line.
    Bussolino F; Tessari F; Turrini F; Braquet P; Camussi G; Prosdocimi M; Bosia A
    Am J Physiol; 1988 Oct; 255(4 Pt 1):C559-65. PubMed ID: 3177629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.